These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6358351)

  • 1. Sensitized (T6 X RFM)F1 donor B cells are engrafted and synthesize antibodies without further antigenic stimulation in RFM recipients with allogenic host-vs-graft disease.
    Hard RC; Carter WH; Bick PH
    J Immunol; 1983 Dec; 131(6):2623-9. PubMed ID: 6358351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitized (T6 x RFM)F1 donor B cells contribute to hypergammaglobulinemia and to poor primary responses in RFM mice with allogenic host versus graft disease.
    Hard RC; Benson LL
    Cell Immunol; 1986 Sep; 101(2):593-603. PubMed ID: 3489542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.
    Hard RC
    Clin Exp Immunol; 1975 Nov; 22(2):330-40. PubMed ID: 1082403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.
    Hard RC; Patel MR; Keller LM; Linna TJ
    Immunology; 1988 Mar; 63(3):457-64. PubMed ID: 3258280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent difference in the roles of spleen and lymph nodes in the pathogenesis of host-versus-graft disease in murine parent/F1 chimeras.
    Hard RC; Benson LL; Keller LM
    Transplantation; 1987 Sep; 44(3):434-9. PubMed ID: 3498242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential changes in serum immunoglobulin levels in young RFM mice with host-versus-graft disease.
    Hard RC
    Immunology; 1980 Apr; 39(4):453-61. PubMed ID: 7380475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of murine leukemia viruses in RFM mice with host versus graft disease after perinatal inoculation of (T6 X RFM)F1 lymphohemopoietic cells.
    Cross SS; Brede G; Tucker HS; Maloney M; Montour JL; Hard RC
    Infect Immun; 1983 Aug; 41(2):570-7. PubMed ID: 6135664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased IL-6 production and IL-6-mediated Ig secretion in murine host-vs-graft disease.
    Vandenabeele P; Abramowicz D; Berus D; Van der Heyden J; Grooten J; Donckier V; Hooghe-Peters EL; Goldman M; Fiers W
    J Immunol; 1993 May; 150(9):4179-87. PubMed ID: 8473756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status of T- and B-lymphocytes in long living CBA--F1 (CBA X C57BL/6) chimeras].
    Cherniakhovskaia IIu; Nesterenko VG; Filitis LN; Fontalin LN; Novikova TK
    Biull Eksp Biol Med; 1978 Aug; 86(8):197-200. PubMed ID: 28802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosuppression of B cells in vitro by graft-vs.-host reaction-derived T cells is caused by cytotoxic T lymphocytes.
    Rozendaal L; Pals ST; Schilham M; Melief CJ; Gleichmann E
    Eur J Immunol; 1989 Sep; 19(9):1669-75. PubMed ID: 2792183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
    Shand FL
    Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma prevents Th2 cell-mediated pathology after neonatal injection of semiallogenic spleen cells in mice.
    Donckier V; Abramowicz D; Bruyns C; Florquin S; Vanderhaeghen ML; Amraoui Z; Dubois C; Vandenabeele P; Goldman M
    J Immunol; 1994 Sep; 153(6):2361-8. PubMed ID: 8077653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.
    Sado T; Kamisaku H; Kubo E
    J Immunol; 1985 Feb; 134(2):704-10. PubMed ID: 3880789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
    Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
    Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs-host disease. IV. Activation of donor allosuppressor cells is confined to acute GVHD.
    Pals ST; Radaszkiewicz T; Gleichmann E
    J Immunol; 1984 Apr; 132(4):1669-78. PubMed ID: 6230390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune competence of splenic lymphocytes following graft-vs-host disease in mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1977 Feb; 118(2):657-61. PubMed ID: 14214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.